Current Epidemiology and Infection Characteristics of Non- Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciag029 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Chin Fen Neoh und 30 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Fungi, Mycoses, Invasive Fungal Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Gilead Fellowship.
Abstract (Originalsprache)
Background
Understanding the epidemiology of invasive non-Aspergillus mold infections is essential to inform effective therapy. This study aimed to determine the epidemiology and infection characteristics of non-Aspergillus mold infections in Australasia.
Methods
A 21-center, retrospective study of proven/probable non-Aspergillus mold infections from 2016 to 2023 was conducted in Australia and New Zealand. Data collected included demographic, clinical, microbiological, treatment, and outcome information through 180 days of follow-up.
Results
Of 421 cases, 346 (82.2%) were proven infections and 315 (74.8%) were localized. Lung (n = 150, 35.6%) was the most common site of infection. Twenty cases (4.8%) were due to >1 non-Aspergillus mold pathogen, resulting in 443 isolates in total. Dematiaceous molds, inclusive of Lomentospora prolificans (n = 96 of 443, 21.7%), Scedosporium spp. (n = 87 of 443, 19.6%), and other dematiaceous molds of various genera (n = 48 of 443, 10.8%), were the most common (n = 231 of 443, 52.1%), followed by Mucorales (n = 141 of 443, 31.8%). Common underlying conditions were hematological malignancy (n = 146, 34.7%) and diabetes mellitus (n = 122, 29.0%), while 68 cases (16.2%) had no comorbidities. One-third (n = 138, 32.8%) of patients received antifungal prophylaxis 30 days before non-Aspergillus mold diagnosis, and L. prolificans was the most common cause of breakthrough infections (P < .001). All-cause 90-day mortality was 31.4% (n = 132 of 421), with higher mortality observed in L. prolificans (n = 51 of 89, 57.3%) and Mucorales (n = 56 of 129, 43.4%) infections.
Conclusions
Lomentospora prolificans, Scedosporium spp., and Mucorales are the most frequent non-Aspergillus mold pathogens in Australasia, with other emerging species and mixed infections encountered. Mortality from L. prolificans and Mucorales infections remains high.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
- Clinical Mycology Reference Laboratory, Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Westmead Hospital, Sydney, New South Wales, Australia.
- University of Sydney Institute of Infectious Diseases, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Department of Clinical Microbiology, LabPlus, New Zealand Mycology Reference Laboratory, Auckland, New Zealand.
ORCID-Profile: Chin Fen Neoh, Sharon C A Chen, Arthur J Morris, Christopher H Heath, Shu Jin Tan, Rebekah Lane, Sebastiaan J van Hal, Robert Pickles, Karen Urbancic, Adam Stewart, Julia C Howard, Caitlin Keighley, Rohan Beresford, Louise Cooley, Sarah Kidd, David C M Kong, Tim Spelman
Förderung
- Gilead Fellowship
Zitieren
APA
Neoh, C. F., Chen, S. C. A., Morris, A. J., Heath, C. H., Tan, S. J., Lane, R., Tio, S. Y., Tay, S. Y., Roberts, M. B., Kennedy, K., van Hal, S. J., Murray, H. C., Pickles, R., Vaselli, N. M., Douglas, A., Urbancic, K., Menon, M., Stewart, A., Howard, J. C., …, & Australian and New Zealand Study Group for non-Aspergillus Mold Infections (2026). Current Epidemiology and Infection Characteristics of Non- Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag029
Vancouver
Neoh CF, Chen SCA, Morris AJ, Heath CH, Tan SJ, Lane R, et al. Current Epidemiology and Infection Characteristics of Non- Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag029
BibTeX
@article{Neoh2026,
author = {Neoh, Chin Fen and Chen, Sharon C A and Morris, Arthur J and Heath, Christopher H and Tan, Shu Jin and Lane, Rebekah and Tio, Shio Yen and Tay, Sze Yen and Roberts, Matthew B and Kennedy, Karina and van Hal, Sebastiaan J and Murray, Hugh C and Pickles, Robert and Vaselli, Natasha Marcella and Douglas, Abby and Urbancic, Karen and Menon, Mahesh and Stewart, Adam and Howard, Julia C and Keighley, Caitlin and Miyakis, Spiros and Beresford, Rohan and Cooley, Louise and Sehu, Marjoree and Halliday, Catriona L and Kidd, Sarah and Kong, David C M and Spelman, Tim and Worth, Leon J and Slavin, Monica A and Australian and New Zealand Study Group for non-Aspergillus Mold Infections, Australian and New Zealand Study Group for non-Aspergillus Mold Infections},
title = {Current Epidemiology and Infection Characteristics of Non- Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag029}
}
EUVIMED